Captrust Financial Advisors Avid Bioservices, Inc. Transaction History

Captrust Financial Advisors

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$4.64 - $9.56 $47,263 - $97,378	10,186 New	10,186 $66,000
Q2 2022 Aug 23, 2022	SELL	$11.63 - $21.55 $66,581 - $123,373	-5,725 Reduced 75.04%	1,904 $29,000
Q2 2022 Aug 16, 2022	BUY	$11.63 - $21.55 $55,940 - $103,655	4,810 Added 170.63%	7,629 $116,000
Q1 2022 May 16, 2022	BUY	$16.63 - $27.73 $8,680 - $14,475	522 Added 22.73%	2,819 $57,000
Q4 2021 Feb 14, 2022	SELL	$20.7 - $34.18 $12,109 - $19,995	-585 Reduced 20.3%	2,297 $67,000
Q2 2021 Aug 16, 2021	SELL	$18.93 - $25.65 $156,267 - $211,740	-8,255 Reduced 74.12%	2,882 $74,000
Q1 2021 May 17, 2021	SELL	$11.86 - $21.77 $39,315 - $72,167	-3,315 Reduced 22.94%	11,137 $203,000
Q4 2020 Feb 16, 2021	BUY	$7.25 - $11.76 $57,202 - $92,786	7,890 Added 120.24%	14,452 $167,000
Q3 2020 Nov 17, 2020	BUY	$6.53 - $8.6 $42,836 - $56,416	6,560 Added 328000.0%	6,562 $51,000
Q2 2020 Aug 14, 2020	BUY	$4.11 - $6.78 $8 - $13	2 New	2 $0
Q4 2019 Feb 14, 2020	SELL	$5.01 - $8.16 $25 - $40	-5 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$5.07 - $7.08 $20 - $28	4 Added 400.0%	5 $0
Q2 2019 Aug 13, 2019	BUY	$3.43 - $5.6 $3 - $5	1 New	1 $0

209

67.1M

216K

4.6K

Ticker CDMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,167,500
Market Cap $776M
Description
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.